Christina Pohlman: Anticoagulants and Bone Health – APS Awareness Month Day 23
Christina Pohlman, CEO and Co-Founder of APS Foundation of America, shared a post on LinkedIn:
“Anticoagulants and Bone Health – APS Awareness Month Day 23
Anticoagulants are medications that help prevent blood clots, but there’s a growing conversation about their impact on bone health.
While these medications are life-saving for many, they can have side effects that might affect your bones over time.
Evidence suggests that long-term use of certain anticoagulants, especially warfarin, may be linked to reduced bone density, increasing the risk of fractures.
It’s essential to balance the need for anticoagulation with maintaining bone health, especially for individuals at a higher risk of osteoporosis.
If you’re on anticoagulant therapy, it’s a good idea to discuss with your healthcare provider about monitoring your bone health.
They might recommend lifestyle modifications, like increased calcium and vitamin D intake, regular weight-bearing exercises, or possibly even discussing other anticoagulant options.
Your bones play a critical role in overall health, so always stay informed and proactive about your bone density alongside your anticoagulant treatment.”

Other posts featuring Christina Pohlman on Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering